1. Immune checkpoint inhibitors in the treatment of virus-associated cancers
   Peipei Gao et al, 2019, Journal of Hematology & Oncology CrossRef
2. PD-L1 Expression on Tumor Cells Is Associated With a Poor Outcome in a Cohort of Caucasian Nasopharyngeal Carcinoma Patients
   Christoph Minichsdorfer et al, 2019, Frontiers in Oncology CrossRef
3. Prognostic value of immune checkpoint molecules in head and neck cancer: a meta-analysis
   Yi-Qun Jia et al, 2019, Aging CrossRef
4. Prognostic Value of Programmed Cell Death Ligand-1 Expression in Nasopharyngeal Carcinoma: A Meta-Analysis of 1,315 Patients
   Xiaofeng Liu et al, 2019, Frontiers in Oncology CrossRef
5. Epstein–Barr Virus LMP1 Induces Soluble PD-L1 in Nasopharyngeal Carcinoma
   Kina Kase et al, 2021, Microorganisms CrossRef